Why Invest in the Health Clinic Market
We sat down and spoke with industry expert Andre Ulloa, Partner and Executive Advisor of M&A Healthcare Advisors, to discuss the key considerations investors should know before investing in the health clinic market. Ulloa sheds light on the factors driving the recent surge in health clinic investment, and what’s to come for this booming market. What is a Health Clinic? A health clinic, also called a walk-in clinic, is a convenient option for immediate, non-emergency medical care. These types of clinics can treat a wide range of conditions, such as the flu, strep throat, small cuts and skin infections. They can also provide services like physical exams, immunizations and similar... Read More »
Navigating Labor Headwinds in Home Health
More than three-quarters of Americans ages 50 and older want to age in place, according to an AARP survey. This comes as The U.S. Administration on Community Living projects the number of Americans aged 65 and older will rise to 80.8 million by 2040, creating significant demand for home health delivery models in the United States. But now, with the HH&H sector approaching a projected global shortage of 10 million health workers by 2030, according to the World Health Organization, the labor issues we’re already seeing in the space are only going to worsen. The labor issues have profound implications for M&A activity within the sector. According to LevinPro HC data, deal volume in... Read More »
Noteworthy Deals of The Second Quarter of 2023
With 586 transactions in the second quarter of 2023, we want to take a moment to look at several that are interesting, whether in purchase price or size of assets. Merck & Co. Acquires Prometheus Biosciences On April 17, Merck & Co announced that it acquired Prometheus Biosciences for $10.8 billion. Prometheus Biosciences is a clinical-stage biotechnology company that specializes in treating immune-mediated diseases. This acquisition represents the largest purchase price of the quarter, regardless of sector. Robert M. Davis, chairman and chief executive officer of Merck had this to say. “The Prometheus acquisition accelerates our growing presence in immunology,... Read More »
Medicare Is Driving the Shift to Value-Based Care
Takeaways from AHLA’s Health Care Transactions Conference Value-based care has arrived and it is here to stay. That was the consensus shared by panelists at the Health Care Transactions conference hosted by the American Health Law Association in April 2023 in Nashville. “Throughout my entire career, I’ve been hearing that value-based care is ‘maybe only five years away,’” Jim Cotelingam, the chief strategy officer for the Cleveland Clinic, said during the opening panel. “I’ve been hearing that for 25 years. But I think this time is actually different.” Levin Associates was in attendance at the conference and the insights shared below are from panel... Read More »
Recap of Cain Brothers Industry Insights
Last week, Jonah Schutzman, of Cain Brothers, provided banker commentary on the current state of physician specialty consolidation in the company’s weekly Industry Insights report. In short, the pandemic ignited an acceleration of consolidation among physicians with non-IDN (integrated delivery network) corporations that included insurers, private equity groups and non-provider umbrella organizations at the forefront. The report referenced data from an Avalere and Physicians Advocacy Institute report showing that three out of four physicians are employed by a non-physician-owned company, which represents a 19% increase from the previous three years. In contrast, hospitals employ more than... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
